TG Therapeutics quarterly revenue jumps 60.7% to $259.9 million
TG Therapeutics' revenue growth is slowing. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Nov 9, 2026.
$TGTX
63.34▼ −0.06%
Latest Research
Latest · 2026-11-09
Coverage Timeline
2026-11-09